Northern Trust’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$463K Sell
510,462
-1,029,124
-67% -$934K ﹤0.01% 3671
2025
Q1
$695K Buy
1,539,586
+265,094
+21% +$120K ﹤0.01% 3433
2024
Q4
$640K Sell
1,274,492
-81
-0% -$41 ﹤0.01% 3567
2024
Q3
$1.15M Buy
1,274,573
+83,255
+7% +$75.4K ﹤0.01% 3302
2024
Q2
$1.19M Sell
1,191,318
-41,228
-3% -$41.1K ﹤0.01% 3169
2024
Q1
$1.82M Buy
1,232,546
+37,362
+3% +$55.3K ﹤0.01% 3007
2023
Q4
$1.3M Sell
1,195,184
-8,773
-0.7% -$9.56K ﹤0.01% 3216
2023
Q3
$1.42M Buy
1,203,957
+100,825
+9% +$119K ﹤0.01% 3120
2023
Q2
$1.56M Buy
1,103,132
+866,049
+365% +$1.22M ﹤0.01% 3160
2023
Q1
$356K Buy
237,083
+13,633
+6% +$20.5K ﹤0.01% 3595
2022
Q4
$261K Hold
223,450
﹤0.01% 3739
2022
Q3
$252K Buy
223,450
+21,675
+11% +$24.4K ﹤0.01% 3759
2022
Q2
$319K Sell
201,775
-829,034
-80% -$1.31M ﹤0.01% 3701
2022
Q1
$1.59M Sell
1,030,809
-50,115
-5% -$77.2K ﹤0.01% 3207
2021
Q4
$2.65M Sell
1,080,924
-416,703
-28% -$1.02M ﹤0.01% 3080
2021
Q3
$3.77M Sell
1,497,627
-131,122
-8% -$330K ﹤0.01% 2920
2021
Q2
$4.64M Buy
1,628,749
+1,332,456
+450% +$3.8M ﹤0.01% 2880
2021
Q1
$696K Buy
296,293
+34,264
+13% +$80.5K ﹤0.01% 3719
2020
Q4
$461K Sell
262,029
-7,027
-3% -$12.4K ﹤0.01% 3747
2020
Q3
$252K Buy
269,056
+25,921
+11% +$24.3K ﹤0.01% 3764
2020
Q2
$211K Sell
243,135
-1,039,421
-81% -$902K ﹤0.01% 3747
2020
Q1
$1.06M Buy
1,282,556
+124,855
+11% +$103K ﹤0.01% 3192
2019
Q4
$1.03M Sell
1,157,701
-43,658
-4% -$38.9K ﹤0.01% 3386
2019
Q3
$1.18M Sell
1,201,359
-42,023
-3% -$41.2K ﹤0.01% 3337
2019
Q2
$1.37M Buy
1,243,382
+11,067
+0.9% +$12.2K ﹤0.01% 3250
2019
Q1
$1.61M Buy
1,232,315
+238,762
+24% +$313K ﹤0.01% 3195
2018
Q4
$907K Sell
993,553
-146,524
-13% -$134K ﹤0.01% 3395
2018
Q3
$2.34M Sell
1,140,077
-21,469
-2% -$44.1K ﹤0.01% 3129
2018
Q2
$2.09M Buy
1,161,546
+56,896
+5% +$103K ﹤0.01% 3184
2018
Q1
$2.6M Buy
1,104,650
+54,815
+5% +$129K ﹤0.01% 2970
2017
Q4
$1.98M Buy
1,049,835
+58,153
+6% +$109K ﹤0.01% 3145
2017
Q3
$2.46M Buy
991,682
+619,041
+166% +$1.54M ﹤0.01% 3054
2017
Q2
$1.03M Sell
372,641
-643,337
-63% -$1.77M ﹤0.01% 3438
2017
Q1
$3.07M Buy
1,015,978
+167,504
+20% +$506K ﹤0.01% 2853
2016
Q4
$2.68M Buy
848,474
+33,168
+4% +$105K ﹤0.01% 2928
2016
Q3
$2.78M Buy
815,306
+15,062
+2% +$51.4K ﹤0.01% 2886
2016
Q2
$1.83M Buy
800,244
+84,567
+12% +$193K ﹤0.01% 3089
2016
Q1
$1.8M Sell
715,677
-25,716
-3% -$64.6K ﹤0.01% 3047
2015
Q4
$2.45M Buy
741,393
+59,046
+9% +$195K ﹤0.01% 2931
2015
Q3
$1.65M Buy
682,347
+32,400
+5% +$78.4K ﹤0.01% 3141
2015
Q2
$1.91M Sell
649,947
-3,479
-0.5% -$10.2K ﹤0.01% 3088
2015
Q1
$2.62M Buy
653,426
+631
+0.1% +$2.53K ﹤0.01% 2952
2014
Q4
$1.97M Sell
652,795
-17,043
-3% -$51.3K ﹤0.01% 3114
2014
Q3
$1.7M Buy
669,838
+123,598
+23% +$313K ﹤0.01% 3204
2014
Q2
$1.35M Sell
546,240
-24,051
-4% -$59.2K ﹤0.01% 3282
2014
Q1
$1.52M Sell
570,291
-44,053
-7% -$117K ﹤0.01% 3259
2013
Q4
$1.79M Buy
614,344
+9,847
+2% +$28.6K ﹤0.01% 3208
2013
Q3
$1.85M Buy
604,497
+53,812
+10% +$165K ﹤0.01% 3131
2013
Q2
$1.76M Buy
+550,685
New +$1.76M ﹤0.01% 3061